• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    FitLife Brands Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8/13/25 4:49:07 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $FTLF alert in real time by email
    ftlf20250813_8k.htm
    false 0001374328 0001374328 2025-08-12 2025-08-12
     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549
     
    FORM 8-K
     
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the
    Securities Exchange Act of 1934
     
    Date of report (Date of earliest event reported): August 12, 2025
     
    Commission File Number: 000-52369
     
     
    FitLife Brands, Inc.
    (Exact name of registrant as specified in its charter.)
     
    Nevada
    20-3464383
    (State or other jurisdiction of incorporation or organization)
    (IRS Employer Identification No.)
     
    5214 S. 136th Street, Omaha, Nebraska 68137
    (Address of principal executive offices)
     
    402-333-5260
    (Registrant's Telephone number)
     
    Not Applicable
    (Former Name or Former Address, if Changed Since Last Report)
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     
    Securities registered pursuant to Section 12(b) of the Act:
     
    Title of each class
    Trading Symbol(s)
    Name of exchange on which registered
    Common Stock, par value $0.01 per share
    FTLF
    Nasdaq Capital Market
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2)
    Emerging growth company ☐ 
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
     
     

     
     
    Item 5.07    Submission of Matters to a Vote of Security Holders.
     
    On August 12, 2025, FitLife Brands, Inc. held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”). The matters voted upon at the Annual Meeting and the results of the voting are set forth below.
     
    Proposal No. 1 – Election of Directors
     
       
    For
       
    Withhold
     
    Dayton Judd
      6,586,405     4,528  
    Grant Dawson
      6,516,060     74,873  
    Matt Lingenbrink
      6,523,190     67,743  
    Seth Yakatan
      6,425,713     165,220  
    Shannon Pappas
      6,523,190     67,743  
     
    The Company’s Directors are elected by a plurality of the votes cast. Accordingly, each of the nominees named above were elected to serve on the Board of Directors until the 2026 Annual Meeting of Stockholders, or until their successors are elected and qualified.
     
    Proposal No. 2 – Advisory Vote to Approve Executive Compensation
     
       
    For
       
    Against
       
    Abstain
     
    Votes
      6,521,001     64,922     5,010  
     
    The vote required to approve the non-binding advisory vote on executive compensation paid to the Company’s named executive officers was the affirmative vote of a majority of the votes cast on the proposal. Accordingly, the Company’s stockholders approved, on a non-binding advisory basis, the compensation paid to the Company’s named executive officers, as reported in the Company’s definitive proxy statement filed on June 24, 2025. 
     
    Proposal No. 3 – Advisory Vote to Approve the Frequency of Advisory Votes on Executive Compensation
     
       
    1 Year
       
    2 Years
       
    3 Years
       
    Abstain
     
    Votes
        605,602     2,695     5,979,100     3,536  
     
    Based upon the results of the advisory votes of this Proposal No. 3, the Board has determined that a non-binding advisory vote on executive compensation will be presented to stockholders every three years. The next required vote on the frequency of such advisory vote on executive compensation will be at the Company’s 2031 Annual Meeting of Stockholders. 
     
    Proposal No. 4 – Ratification of Appointment of Auditors
     
       
    For
       
    Against
       
    Abstain
     
    Votes
      8,161,128     10     6  
     
    The vote required to approve this proposal was the affirmative vote of a majority of the votes cast on the proposal. Accordingly, stockholders ratified the appointment of Weinberg & Company, P.A. as the Company’s independent auditors for the fiscal year ending December 31, 2025.
     
     

     
     
    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
     
     
    FitLife Brands, Inc.
     
           
    August 13, 2025
    By:
    /s/ Dayton Judd
     
       
    Dayton Judd
     
       
    Chief Executive Officer
     
     
     
    Get the next $FTLF alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FTLF

    DatePrice TargetRatingAnalyst
    3/17/2025$21.00Buy
    Lake Street
    9/3/2024$40.00Buy
    ROTH MKM
    More analyst ratings

    $FTLF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ordal Todd bought $3,621 worth of shares (300 units at $12.07), increasing direct ownership by 0.48% to 62,488 units (SEC Form 4)

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    4/16/25 8:00:07 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Lingenbrink Matthew bought $36,510 worth of shares (3,000 units at $12.17), increasing direct ownership by 107% to 5,800 units (SEC Form 4)

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    4/16/25 8:00:05 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Lingenbrink Matthew bought $34,089 worth of shares (2,800 units at $12.17) (SEC Form 4)

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    4/2/25 8:01:06 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    $FTLF
    SEC Filings

    View All

    FitLife Brands Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - FITLIFE BRANDS, INC. (0001374328) (Filer)

    8/19/25 4:30:41 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - FITLIFE BRANDS, INC. (0001374328) (Filer)

    8/14/25 7:30:27 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 10-Q filed by FitLife Brands Inc.

    10-Q - FITLIFE BRANDS, INC. (0001374328) (Filer)

    8/14/25 7:00:49 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    $FTLF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FitLife Brands Announces Second Quarter 2025 Results

    OMAHA, NE, Aug. 14, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the second quarter ended June 30, 2025. Highlights for the second quarter ended June 30, 2025 include: Total revenue was $16.1 million, 5% lower than the second quarter of 2024.  Online revenue was $10.4 million, representing 65% of total revenue and down 7% compared to the second quarter of 2024.Gross margin was 42.8% compared to 44.8% during the second quarter of 2024.Net income for the second quarter of 2025 was $1.7 million compared to $2.6 million dur

    8/14/25 7:00:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Closes Acquisition of Irwin Naturals

    OMAHA, NE, Aug. 11, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that on August 8, 2025, it successfully closed the acquisition of substantially all of the assets of Irwin Naturals and its related affiliates ("Irwin") as previously approved by the US Bankruptcy Court for the Central District of California.  Through the asset purchase transaction under Section 363 of the US Bankruptcy Code, the Company acquired substantially all of the assets and assumed minimal liabilities of Irwin.  Total consideration for the acquisition was $42.5 million.

    8/11/25 7:00:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands to Acquire Irwin Naturals

    OMAHA, NE, Aug. 05, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, announced that it has entered into definitive documentation and received requisite approvals to acquire substantially all of the assets of Irwin Naturals and its related affiliates ("Irwin") under Section 363 of the US Bankruptcy Code (the "Transaction"). Highlights of the Transaction, which is expected to close on or about August 8, 2025, are as follows: The Transaction will approximately double the size of the Company, with consolidated revenue for the combined business anticipated to be in

    8/5/25 6:00:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    $FTLF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Hansen Ryan P. claimed ownership of 25,678 shares (SEC Form 3)

    3 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    5/12/25 7:27:11 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 3 filed by new insider Pappas Shannon K.

    3 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    5/12/25 7:26:27 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Ordal Todd bought $3,621 worth of shares (300 units at $12.07), increasing direct ownership by 0.48% to 62,488 units (SEC Form 4)

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    4/16/25 8:00:07 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    $FTLF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street initiated coverage on FitLife Brands with a new price target

    Lake Street initiated coverage of FitLife Brands with a rating of Buy and set a new price target of $21.00

    3/17/25 8:22:47 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    ROTH MKM initiated coverage on FitLife Brands with a new price target

    ROTH MKM initiated coverage of FitLife Brands with a rating of Buy and set a new price target of $40.00

    9/3/24 7:48:49 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    $FTLF
    Financials

    Live finance-specific insights

    View All

    FitLife Brands Announces Second Quarter 2025 Results

    OMAHA, NE, Aug. 14, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the second quarter ended June 30, 2025. Highlights for the second quarter ended June 30, 2025 include: Total revenue was $16.1 million, 5% lower than the second quarter of 2024.  Online revenue was $10.4 million, representing 65% of total revenue and down 7% compared to the second quarter of 2024.Gross margin was 42.8% compared to 44.8% during the second quarter of 2024.Net income for the second quarter of 2025 was $1.7 million compared to $2.6 million dur

    8/14/25 7:00:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands to Acquire Irwin Naturals

    OMAHA, NE, Aug. 05, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, announced that it has entered into definitive documentation and received requisite approvals to acquire substantially all of the assets of Irwin Naturals and its related affiliates ("Irwin") under Section 363 of the US Bankruptcy Code (the "Transaction"). Highlights of the Transaction, which is expected to close on or about August 8, 2025, are as follows: The Transaction will approximately double the size of the Company, with consolidated revenue for the combined business anticipated to be in

    8/5/25 6:00:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Announces Second Quarter Earnings Call

    OMAHA, NE, Aug. 01, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the second quarter of fiscal 2025 on Thursday, August 14, 2025. In addition, the Company announced that it will hold an investor conference call after market close on August 14, 2025 at 4:30 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 759665.  International participants can dial (973) 528-0163 and provide the same code.

    8/1/25 8:30:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    $FTLF
    Leadership Updates

    Live Leadership Updates

    View All

    FitLife Brands Announces Board Transition

    Omaha, NE, April 28, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, announced today the resignation of Todd Ordal as a member of the Company's Board of Directors. Mr. Ordal's resignation, effective on April 25, 2025, was part of the Company's ongoing commitment to refresh board composition on a regular basis in accordance with good corporate governance practices and was not the result of any disagreement with the Company's management or the Board of Directors regarding any matter related to the Company or otherwise. On April 25, 2025, the Board of Directors of

    4/28/25 7:30:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    LifeVantage Appoints Dayton Judd to the Board of Directors

    SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the appointment of Dayton Judd to the Company's Board of Directors (the "Board"), effective immediately, in an expansion of the Board. The Company has had discussions with Bradley L. Radoff and Sudbury Capital Fund, LP (collectively with certain of their affiliates, the "Radoff-Sudbury Group"), which owns approximately 12.6% of the Company's outstanding stock, since the Company's fiscal year 2024 annual meeting of shareholders held on November 6, 2023. During these dis

    2/15/24 4:05:00 PM ET
    $FTLF
    $LFVN
    $OPXS
    Medicinal Chemicals and Botanical Products
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Electronic Components